Orthex Q1: Excellent growth in all product categories and market areas
Orthex Corporation, Stock exchange release, May 11, 2021 at 9.00 a.m. EEST This release is a summary of Orthex Corporation’s Interim Report January–March 2021. The complete report is attached to this release as a pdf-file. It is also available on Orthex’s website at https://investors.orthexgroup.com/.January–March 2021 in Brief · Invoiced sales increased by 33.5% and was EUR 22.4 million (16.8) · Net sales increased by 32.4% to EUR 21.6 million (16.3) · Adjusted EBITDA was EUR 4.3 million (3.0) (adjusted for IPO related costs EUR 1.3 million) · EBITA was EUR 2.0 million (1.